Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 167503, 7 pages
http://dx.doi.org/10.1155/2015/167503
Review Article

Zinc Transporters and Zinc Signaling: New Insights into Their Role in Type 2 Diabetes

University of Tasmania (UTAS), School of Health Sciences, Newnham Campus, Launceston, TAS 7250, Australia

Received 25 February 2015; Revised 7 April 2015; Accepted 12 April 2015

Academic Editor: Amelie Bonnefond

Copyright © 2015 Stephen A. Myers. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Casey, “The sugar disease—understanding type 2 diabetes mellitus,” Kai Tiaki Nursing New Zealand, vol. 17, no. 2, pp. 16–21, 2011. View at Google Scholar
  2. G. Smushkin and A. Vella, “What is type 2 diabetes?” Medicine, vol. 38, no. 11, pp. 597–601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Bagnasco, P. di Giacomo, R. da Rin Della Mora et al., “Factors influencing self-management in patients with type 2 diabetes: a quantitative systematic review protocol,” Journal of Advanced Nursing, vol. 70, no. 1, pp. 187–200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Shen, H. Edwards, M. Courtney, J. Mcdowell, and J. Wei, “Barriers and facilitators to diabetes self-management: perspectives of older community dwellers and health professionals in China,” International Journal of Nursing Practice, vol. 19, no. 6, pp. 627–635, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Fukada, S. Yamasaki, K. Nishida, M. Murakami, and T. Hirano, “Zinc homeostasis and signaling in health and diseases,” Journal of Biological Inorganic Chemistry, vol. 16, no. 7, pp. 1123–1134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Haase and L. Rink, “Zinc signaling,” in Zinc in Human Health, L. Rink, Ed., p. 577, IOS Press, Amsterdam, The Netherlands, 2011. View at Google Scholar
  7. H. Haase and W. Maret, “Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling,” Experimental Cell Research, vol. 291, no. 2, pp. 289–298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Haase and W. Maret, “Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases,” Journal of Trace Elements in Medicine and Biology, vol. 19, no. 1, pp. 37–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Jansen, E. Rosenkranz, S. Overbeck et al., “Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc,” Journal of Nutritional Biochemistry, vol. 23, no. 11, pp. 1458–1466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. King, D. M. Shames, and L. R. Woodhouse, “Zinc homeostasis in humans,” The Journal of Nutrition, vol. 130, no. 5, pp. 1360S–1366S, 2000. View at Google Scholar · View at Scopus
  11. Y. Yoshikawa, E. Ueda, Y. Kojima, and H. Sakurai, “The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes,” Life Sciences, vol. 75, no. 6, pp. 741–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Yamasaki, K. Sakata-Sogawa, A. Hasegawa et al., “Zinc is a novel intracellular second messenger,” The Journal of Cell Biology, vol. 177, no. 4, pp. 637–645, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. X.-H. Tang and N. F. Shay, “Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes,” Journal of Nutrition, vol. 131, no. 5, pp. 1414–1420, 2001. View at Google Scholar · View at Scopus
  14. H. P. Roth and M. Kirchgessner, “Zinc and insulin metabolism,” Biological Trace Element Research, vol. 3, no. 1, pp. 13–32, 1981. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Myers, A. Nield, and M. Myers, “Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus,” Journal of Nutrition and Metabolism, vol. 2012, Article ID 173712, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. May and C. S. Contoreggi, “The mechanism of the insulin-like effects of ionic zinc,” The Journal of Biological Chemistry, vol. 257, no. 8, pp. 4362–4368, 1982. View at Google Scholar · View at Scopus
  17. E. Mocchegiani, R. Giacconi, and M. Malavolta, “Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes,” Trends in Molecular Medicine, vol. 14, no. 10, pp. 419–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. T. Chasapis, C. A. Spiliopoulou, A. C. Loutsidou, and M. E. Stefanidou, “Zinc and human health: an update,” Archives of Toxicology, vol. 86, no. 4, pp. 521–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Jansen, W. Karges, and L. Rink, “Zinc and diabetes—clinical links and molecular mechanisms,” Journal of Nutritional Biochemistry, vol. 20, no. 6, pp. 399–417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Maret, “Analyzing free zinc(ii) ion concentrations in cell biology with fluorescent chelating molecules,” Metallomics, vol. 7, no. 2, pp. 202–211, 2015. View at Publisher · View at Google Scholar
  21. K. R. Gee, Z.-L. Zhou, W.-J. Qian, and R. Kennedy, “Detection and imaging of zinc secretion from pancreatic, β-cells using a new fluorescent zinc indicator,” Journal of the American Chemical Society, vol. 124, no. 5, pp. 776–778, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Tomat and S. J. Lippard, “Imaging mobile zinc in biology,” Current Opinion in Chemical Biology, vol. 14, no. 2, pp. 225–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. L. Figueroa, K. S. Vignesh, G. S. Deepe Jr., and J. Caruso, “Selectivity and specificity of small molecule fluorescent dyes/probes used for the detection of Zn2+ and Ca2+ in cells,” Metallomics, vol. 6, no. 2, pp. 301–315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. I. A. Brand and J. Kleineke, “Intracellular zinc movement and its effect on the carbohydrate metabolism of isolated rat hepatocytes,” The Journal of Biological Chemistry, vol. 271, no. 4, pp. 1941–1949, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Krezel and W. Maret, “Zinc-buffering capacity of a eukaryotic cell at physiological pZn,” Journal of Biological Inorganic Chemistry, vol. 11, no. 8, pp. 1049–1062, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. Bozym, R. B. Thompson, A. K. Stoddard, and C. A. Fierke, “Measuring picomolar intracellular exchangeable zinc in PC-12 cells using a ratiometric fluorescence biosensor,” ACS Chemical Biology, vol. 1, no. 2, pp. 103–111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. P. J. Dittmer, J. G. Miranda, J. A. Gorski, and A. E. Palmer, “Genetically encoded sensors to elucidate spatial distribution of cellular zinc,” Journal of Biological Chemistry, vol. 284, no. 24, pp. 16289–16297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Maret, “Metals on the move: zinc ions in cellular regulation and in the coordination dynamics of zinc proteins,” BioMetals, vol. 24, no. 3, pp. 411–418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Cousins, J. P. Liuzzi, and L. A. Lichten, “Mammalian zinc transport, trafficking, and signals,” The Journal of Biological Chemistry, vol. 281, no. 34, pp. 24085–24089, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. D. J. Eide, “Zinc transporters and the cellular trafficking of zinc,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1763, no. 7, pp. 711–722, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. L. A. Gaither and D. J. Eide, “Eukaryotic zinc transporters and their regulation,” BioMetals, vol. 14, no. 3-4, pp. 251–270, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Kambe, “An overview of a wide range of functions of ZnT and Zip Zinc transporters in the secretory pathway,” Bioscience, Biotechnology and Biochemistry, vol. 75, no. 6, pp. 1036–1043, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. L. A. Lichten and R. J. Cousins, “Mammalian zinc transporters: nutritional and physiologic regulation,” Annual Review of Nutrition, vol. 29, no. 1, pp. 153–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. P. Liuzzi and R. J. Cousins, “Mammalian zinc transporters,” Annual Review of Nutrition, vol. 24, no. 1, pp. 151–172, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Rungby, “Zinc, zinc transporters and diabetes,” Diabetologia, vol. 53, no. 8, pp. 1549–1551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. D. J. Eide, “An ‘inordinate fondness for transporters’ explained?” Science Signaling, vol. 5, no. 210, p. pe5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Jeong and D. J. Eide, “The SLC39 family of zinc transporters,” Molecular Aspects of Medicine, vol. 34, no. 2-3, pp. 612–619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Milon, Q. Wu, J. Zou, L. C. Costello, and R. B. Franklin, “Histidine residues in the region between transmembrane domains III and IV of hZip1 are required for zinc transport across the plasma membrane in PC-3 cells,” Biochimica et Biophysica Acta—Biomembranes, vol. 1758, no. 10, pp. 1696–1701, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R. D. Palmiter and S. D. Findley, “Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc,” The EMBO Journal, vol. 14, no. 4, pp. 639–649, 1995. View at Google Scholar · View at Scopus
  40. Y. Bi, R. D. Palmiter, K. M. Wood, and Q. Ma, “Induction of metallothionein I by phenolic antioxidants requires metal-activated transcription factor 1 (MTF-1) and zinc,” Biochemical Journal, vol. 380, no. 3, pp. 695–703, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Huang and S. Tepaamorndech, “The SLC30 family of zinc transporters—a review of current understanding of their biological and pathophysiological roles,” Molecular Aspects of Medicine, vol. 34, no. 2-3, pp. 548–560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Ilouz, O. Kaidanovich, D. Gurwitz, and H. Eldar-Finkelman, “Inhibition of glycogen synthase kinase-3β by bivalent zinc ions: insight into the insulin-mimetic action of zinc,” Biochemical and Biophysical Research Communications, vol. 295, no. 1, pp. 102–106, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Moniz, M. J. Amorim, R. Ferreira et al., “Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type i diabetic animals,” Journal of Inorganic Biochemistry, vol. 105, no. 12, pp. 1675–1682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Wijesekara, F. Chimienti, and M. B. Wheeler, “Zinc, a regulator of islet function and glucose homeostasis,” Diabetes, Obesity and Metabolism, vol. 11, no. 4, pp. 202–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Coulston and P. Dandona, “Insulin-like effect of zinc on adipocytes,” Diabetes, vol. 29, no. 8, pp. 665–667, 1980. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Wilson, C. Hogstrand, and W. Maret, “Picomolar concentrations of free zinc(II) ions regulate receptor protein-tyrosine phosphatase β activity,” Journal of Biological Chemistry, vol. 287, no. 12, pp. 9322–9326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Haase and W. Maret, “Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants,” BioMetals, vol. 18, no. 4, pp. 333–338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Tang, H. Le-Tien, B. J. Goldstein, P. Shin, R. Lai, and I. G. Fantus, “Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes,” Diabetes, vol. 50, no. 1, pp. 83–90, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. K. M. Taylor, “A distinct role in breast cancer for two LIV-1 family zinc transporters,” Biochemical Society Transactions, vol. 36, no. 6, pp. 1247–1251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. K. M. Taylor, P. Vichova, N. Jordan, S. Hiscox, R. Hendley, and R. I. Nicholson, “ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cells,” Endocrinology, vol. 149, no. 10, pp. 4912–4920, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. A. R. Cameron, S. Anil, E. Sutherland, J. Harthill, and G. Rena, “Zinc-dependent effects of small molecules on the insulin-sensitive transcription factor FOXO1a and gluconeogenic genes,” Metallomics, vol. 2, no. 3, pp. 195–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Hogstrand, P. Kille, R. I. Nicholson, and K. M. Taylor, “Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation,” Trends in Molecular Medicine, vol. 15, no. 3, pp. 101–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Huang, M. Yan, and C. P. Kirschke, “Over-expression of ZnT7 increases insulin synthesis and secretion in pancreatic β-cells by promoting insulin gene transcription,” Experimental Cell Research, vol. 316, no. 16, pp. 2630–2643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Huang, C. P. Kirschke, Y.-A. E. Lay, L. B. Levy, D. E. Lamirande, and P. H. Zhang, “Znt7-null mice are more susceptible to diet-induced glucose intolerance and insulin resistance,” The Journal of Biological Chemistry, vol. 287, no. 40, pp. 33883–33896, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Smidt, N. Jessen, A. B. Petersen et al., “SLC30A3 responds to glucose- and zinc variations in β-cells and is critical for insulin production and in vivo glucose-metabolism during β-cell stress,” PLoS ONE, vol. 4, no. 5, Article ID e5684, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. E. A. Bellomo, G. Meur, and G. A. Rutter, “Glucose regulates free cytosolic Zn2+ concentration, Slc39 (ZiP), and metallothionein gene expression in primary pancreatic islet β-cells,” Journal of Biological Chemistry, vol. 286, no. 29, pp. 25778–25789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Hojyo, T. Fukada, S. Shimoda et al., “The zinc transporter SLC39A14/ZIP14 controls G-protein coupled receptor-mediated signaling required for systemic growth,” PLoS ONE, vol. 6, no. 3, Article ID e18059, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. S. A. Myers, A. Nield, G.-S. Chew, and M. A. Myers, “The zinc transporter, Slc39a7 (Zip7) is implicated in glycaemic control in skeletal muscle cells,” PLoS ONE, vol. 8, no. 11, Article ID e79316, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. K. M. Taylor, S. Hiscox, R. I. Nicholson, C. Hogstrand, and P. Kille, “Cell biology: Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7,” Science Signaling, vol. 5, no. 210, article ra11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Taniguchi, A. Fukunaka, M. Hagihara et al., “Essential role of the zinc transporter ZIP9/SLC39A9 in regulating the activations of Akt and Erk in B-cell receptor signaling pathway in DT40 Cells,” PLoS ONE, vol. 8, no. 3, Article ID e58022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Zimmet, “Review: epidemiology of diabetes—its history in the last 50 years,” The British Journal of Diabetes & Vascular Disease, vol. 2, no. 6, pp. 435–439, 2002. View at Publisher · View at Google Scholar
  62. I. Hwang, T. Yoon, C. Kim, B. Cho, S. Lee, and M. K. Song, “Different roles of zinc plus arachidonic acid on insulin sensitivity between high fructose- and high fat-fed rats,” Life Sciences, vol. 88, no. 5-6, pp. 278–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Jayawardena, P. Ranasinghe, P. Galappatthy, R. L. D. K. Malkanthi, G. R. Constantine, and P. Katulanda, “Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis,” Diabetology and Metabolic Syndrome, vol. 4, no. 1, article 13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. S. F. Simon and C. G. Taylor, “Dietary zinc supplementation attenuates hyperglycemia in db/db mice,” Experimental Biology and Medicine, vol. 226, no. 1, pp. 43–51, 2001. View at Google Scholar · View at Scopus
  65. M. K. Song, M. J. Rosenthal, S. Hong et al., “Synergistic antidiabetic activities of zinc, cyclo (His-Pro), and arachidonic acid,” Metabolism: Clinical and Experimental, vol. 50, no. 1, pp. 53–59, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. X. Miao, W. Sun, Y. Fu, L. Miao, and L. Cai, “Zinc homeostasis in the metabolic syndrome and diabetes,” Frontiers of Medicine in China, vol. 7, no. 1, pp. 31–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Zhao, Y. Tan, J. Dai et al., “Zinc deficiency exacerbates diabetic down-regulation of Akt expression and function in the testis: essential roles of PTEN, PTP1B and TRB3,” Journal of Nutritional Biochemistry, vol. 23, no. 8, pp. 1018–1026, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Yoshikawa, E. Ueda, H. Sakurai, and Y. Kojima, “Anti-diabetes effect of Zn(II)/carnitine complex by oral administration,” Chemical and Pharmaceutical Bulletin, vol. 51, no. 2, pp. 230–231, 2003. View at Publisher · View at Google Scholar
  69. Y. Adachi, J. Yoshida, Y. Kodera et al., “Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes,” Biochemical and Biophysical Research Communications, vol. 351, no. 1, pp. 165–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Chimienti, A. Favier, and M. Seve, “ZnT-8, a pancreatic beta-cell-specific zinc transporter,” BioMetals, vol. 18, no. 4, pp. 313–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. D. A. Chistiakov and N. V. Voronova, “Zn2+-transporter-8: a dual role in diabetes,” BioFactors, vol. 35, no. 4, pp. 356–363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Kawasaki, K. Nakamura, G. Kuriya et al., “Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 8, pp. 895–898, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Murgia, C. Devirgiliis, E. Mancini, G. Donadel, P. Zalewski, and G. Perozzi, “Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 6, pp. 431–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. T. J. Nicolson, E. A. Bellomo, N. Wijesekara et al., “Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes–associated variants,” Diabetes, vol. 58, no. 9, pp. 2070–2083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. Z. Shan, W. Bao, Y. Zhang et al., “Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes,” Diabetes, vol. 63, no. 5, pp. 1796–1803, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Chimienti, S. Devergnas, F. Pattou et al., “In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion,” Journal of Cell Science, vol. 119, no. 20, pp. 4199–4206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Fu, W. Tian, E. B. Pratt et al., “Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion,” PLoS ONE, vol. 4, no. 5, Article ID e5679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. N. Wijesekara, F. F. Dai, A. B. Hardy et al., “Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion,” Diabetologia, vol. 53, no. 8, pp. 1656–1668, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. L. D. Pound, S. A. Sarkar, R. K. P. Benninger et al., “Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion,” Biochemical Journal, vol. 421, no. 3, pp. 371–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. A. B. Hardy, N. Wijesekara, I. Genkin et al., “Effects of high-fat diet feeding on Znt8-null mice: differences between beta-cell and global knockout of Znt8,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 302, no. 9, pp. E1084–E1096, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. U. J. Kommoju and B. M. Reddy, “Genetic etiology of type 2 diabetes mellitus: a review,” International Journal of Diabetes in Developing Countries, vol. 31, no. 2, pp. 51–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. R. Saxena, B. F. Voight, V. Lyssenko et al., “Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels,” Science, vol. 316, no. 5829, pp. 1331–1336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Sladek, G. Rocheleau, J. Rung et al., “A genome-wide association study identifies novel risk loci for type 2 diabetes,” Nature, vol. 445, no. 7130, pp. 881–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Xu, J. Wang, and B. Chen, “SLC30A8 (ZnT8) variations and type 2 diabetes in the Chinese Han population,” Genetics and Molecular Research, vol. 11, no. 2, pp. 1592–1598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. E. Kawasaki, “ZnT8 and type 1 diabetes,” Endocrine Journal, vol. 59, no. 7, pp. 531–537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. J. M. Wenzlau, K. Juhl, L. Yu et al., “The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17040–17045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Flannick, G. Thorleifsson, N. L. Beer et al., “Loss-of-function mutations in SLC30A8 protect against type 2 diabetes,” Nature Genetics, vol. 46, no. 4, pp. 357–363, 2014. View at Google Scholar
  88. M. Foster, A. Chu, P. Petocz, and S. Samman, “Zinc transporter gene expression and glycemic control in post-menopausal women with Type 2 diabetes mellitus,” Journal of Trace Elements in Medicine and Biology, vol. 28, no. 4, pp. 448–452, 2014. View at Publisher · View at Google Scholar